BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23644884)

  • 1. HDAC6 and ovarian cancer.
    Haakenson J; Zhang X
    Int J Mol Sci; 2013 May; 14(5):9514-35. PubMed ID: 23644884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interplay between G protein-coupled receptor kinase 2 (GRK2) and histone deacetylase 6 (HDAC6) at the crossroads of epithelial cell motility.
    Lafarga V; Mayor F; Penela P
    Cell Adh Migr; 2012; 6(6):495-501. PubMed ID: 23076141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin proteasome system stress underlies synergistic killing of ovarian cancer cells by bortezomib and a novel HDAC6 inhibitor.
    Bazzaro M; Lin Z; Santillan A; Lee MK; Wang MC; Chan KC; Bristow RE; Mazitschek R; Bradner J; Roden RB
    Clin Cancer Res; 2008 Nov; 14(22):7340-7. PubMed ID: 19010849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of histone deacetylase 6 (HDAC6) nuclear import and tubulin deacetylase activity through acetylation.
    Liu Y; Peng L; Seto E; Huang S; Qiu Y
    J Biol Chem; 2012 Aug; 287(34):29168-74. PubMed ID: 22778253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC6 and SIRT2 promote bladder cancer cell migration and invasion by targeting cortactin.
    Zuo Q; Wu W; Li X; Zhao L; Chen W
    Oncol Rep; 2012 Mar; 27(3):819-24. PubMed ID: 22089141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARID1A-mutated ovarian cancers depend on HDAC6 activity.
    Bitler BG; Wu S; Park PH; Hai Y; Aird KM; Wang Y; Zhai Y; Kossenkov AV; Vara-Ailor A; Rauscher FJ; Zou W; Speicher DW; Huntsman DG; Conejo-Garcia JR; Cho KR; Christianson DW; Zhang R
    Nat Cell Biol; 2017 Aug; 19(8):962-973. PubMed ID: 28737768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes.
    Li Y; Shin D; Kwon SH
    FEBS J; 2013 Feb; 280(3):775-93. PubMed ID: 23181831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Interaction of Class IIb Histone Deacetylase 6 (HDAC6) with Class IIa HDAC9 Controls Gonadotropin Releasing Hormone (GnRH) Neuronal Cell Survival and Movement.
    Salian-Mehta S; Xu M; McKinsey TA; Tobet S; Wierman ME
    J Biol Chem; 2015 May; 290(22):14045-56. PubMed ID: 25873389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin.
    Kaluza D; Kroll J; Gesierich S; Yao TP; Boon RA; Hergenreider E; Tjwa M; Rössig L; Seto E; Augustin HG; Zeiher AM; Dimmeler S; Urbich C
    EMBO J; 2011 Aug; 30(20):4142-56. PubMed ID: 21847094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylation of histone deacetylase 6 by p300 attenuates its deacetylase activity.
    Han Y; Jeong HM; Jin YH; Kim YJ; Jeong HG; Yeo CY; Lee KY
    Biochem Biophys Res Commun; 2009 May; 383(1):88-92. PubMed ID: 19344692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions.
    Valenzuela-Fernández A; Cabrero JR; Serrador JM; Sánchez-Madrid F
    Trends Cell Biol; 2008 Jun; 18(6):291-7. PubMed ID: 18472263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugging the HDAC6-HSP90 interplay in malignant cells.
    Krämer OH; Mahboobi S; Sellmer A
    Trends Pharmacol Sci; 2014 Oct; 35(10):501-9. PubMed ID: 25234862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDAC6 modulates cell motility by altering the acetylation level of cortactin.
    Zhang X; Yuan Z; Zhang Y; Yong S; Salas-Burgos A; Koomen J; Olashaw N; Parsons JT; Yang XJ; Dent SR; Yao TP; Lane WS; Seto E
    Mol Cell; 2007 Jul; 27(2):197-213. PubMed ID: 17643370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of deacetylation activity of Hdac6 affects emotional behavior in mice.
    Fukada M; Hanai A; Nakayama A; Suzuki T; Miyata N; Rodriguiz RM; Wetsel WC; Yao TP; Kawaguchi Y
    PLoS One; 2012; 7(2):e30924. PubMed ID: 22328923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of GRK2 in cell signaling beyond GPCR desensitization: GRK2-HDAC6 interaction modulates cell spreading and motility.
    Penela P; Lafarga V; Tapia O; Rivas V; Nogués L; Lucas E; Vila-Bedmar R; Murga C; Mayor F
    Sci Signal; 2012 May; 5(224):pt3. PubMed ID: 22589388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase 6 regulates growth factor-induced actin remodeling and endocytosis.
    Gao YS; Hubbert CC; Lu J; Lee YS; Lee JY; Yao TP
    Mol Cell Biol; 2007 Dec; 27(24):8637-47. PubMed ID: 17938201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the Selective Inhibition of Histone Deacetylase 6.
    Rodrigues DA; Thota S; Fraga CA
    Mini Rev Med Chem; 2016; 16(14):1175-84. PubMed ID: 27121714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase 6 in health and disease.
    Seidel C; Schnekenburger M; Dicato M; Diederich M
    Epigenomics; 2015; 7(1):103-18. PubMed ID: 25687470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.
    Bali P; Pranpat M; Bradner J; Balasis M; Fiskus W; Guo F; Rocha K; Kumaraswamy S; Boyapalle S; Atadja P; Seto E; Bhalla K
    J Biol Chem; 2005 Jul; 280(29):26729-34. PubMed ID: 15937340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SQSTM1/p62 interacts with HDAC6 and regulates deacetylase activity.
    Yan J; Seibenhener ML; Calderilla-Barbosa L; Diaz-Meco MT; Moscat J; Jiang J; Wooten MW; Wooten MC
    PLoS One; 2013; 8(9):e76016. PubMed ID: 24086678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.